Altered peptide epitopes derived from the anti-apoptotic protein ‘survivin’ may stimulate effective anti-glioma immune responses

Principal Investigator: Michael Ciesielski, PhD

Institute: Roswell Park Cancer Institute

Initiative: Glioblastoma Multiforme Grant

Location: Buffalo, NY

Share